Becton Dickinson (BDX) rose 2.4% in premarket trading as reports surface of potential separation of its $30 billion life ...
Medical technology company Becton, Dickinson and Company (NYSE:BDX) will be announcing earnings results tomorrow before ...
So if this idea of high risk and high reward doesn't suit, you might be more interested in profitable, growing companies, like Becton Dickinson (NYSE:BDX). Even if this company is fairly valued by the ...
Becton Dickinson and Co (BDX) stock saw a modest uptick, ending the day at $247.61 which represents a slight increase of $0.01 or 0.00% from the prior close of $247.6. The stock opened at $248.13 and ...
Analysts have been eager to weigh in on the Healthcare sector with new ratings on Becton Dickinson (BDX – Research Report), Idexx Laboratories ...
Becton Dickinson & Co. closed 3.80% short of its 52-week high of $251.99, which the company reached on February 3rd.
Starboard Value has taken a stake in Becton Dickinson (BDX) and is pushing the medical technology company to sell its life sciences division, ...
Shares of Becton, Dickinson and Company (NYSE:BDX – Get Free Report) have earned an average rating of “Buy” from the seven ratings firms that are presently covering the company, MarketBeat.com reports ...
Activist investor Starboard Value is urging Becton Dickinson to sell its life sciences division, citing potential value gains. Analysts estimate a spin-off could boost the company's worth by up to 30% ...
Becton Dickinson (BDX) is expected to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended December 2024. This widely-known consensus ...